- Home
- NPT vs SERA Comparison
NPT vs SERA Comparison
Compare NPT & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPT
- SERA
- Stock Information
- Founded
- NPT 2011
- SERA 2008
- Country
- NPT China
- SERA United States
- Employees
- NPT N/A
- SERA N/A
- Industry
- NPT Specialty Chemicals
- SERA Precision Instruments
- Sector
- NPT Consumer Discretionary
- SERA Health Care
- Exchange
- NPT Nasdaq
- SERA Nasdaq
- Market Cap
- NPT 113.1M
- SERA 90.6M
- IPO Year
- NPT 2025
- SERA 2021
- Fundamental
- Price
- NPT $3.69
- SERA $3.15
- Analyst Decision
- NPT
- SERA
- Analyst Count
- NPT 0
- SERA 0
- Target Price
- NPT N/A
- SERA N/A
- AVG Volume (30 Days)
- NPT 130.5K
- SERA 39.6K
- Earning Date
- NPT 11-18-2025
- SERA 11-13-2025
- Dividend Yield
- NPT N/A
- SERA N/A
- EPS Growth
- NPT N/A
- SERA N/A
- EPS
- NPT N/A
- SERA N/A
- Revenue
- NPT $797,148,640.00
- SERA $95,000.00
- Revenue This Year
- NPT N/A
- SERA $217.92
- Revenue Next Year
- NPT N/A
- SERA $479.25
- P/E Ratio
- NPT N/A
- SERA N/A
- Revenue Growth
- NPT 18.51
- SERA 1.06
- 52 Week Low
- NPT $3.14
- SERA $1.37
- 52 Week High
- NPT $9.18
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- NPT N/A
- SERA 52.08
- Support Level
- NPT N/A
- SERA $2.96
- Resistance Level
- NPT N/A
- SERA $3.18
- Average True Range (ATR)
- NPT 0.00
- SERA 0.27
- MACD
- NPT 0.00
- SERA 0.01
- Stochastic Oscillator
- NPT 0.00
- SERA 75.33
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.